Investigating the genetic changes of the DDX3X gene
Using saturation genome editing, researchers have created a map of disease-causing mutations for neurodevelopmental disorders and cancer.
List view / Grid view
Using saturation genome editing, researchers have created a map of disease-causing mutations for neurodevelopmental disorders and cancer.
Increasing microRNA-22 overexpression in a gene therapy approach treated HCC in mice, offering promise for its prevention and treatment.
A discovery about the mutated protein DECTIN-1, that limits the production of T regulatory cells, could lead to more effective drugs.
A previously unknown process by which pathogens breach immune defences offers promise for treating infectious diseases.
Discovery about the NPM1c variant could lead to new drugs targeting the cell growth of acute myeloid leukaemia.
Our inaugural report is an exploration of the remarkable advancements in RNA and the field of drug discovery.
Our inaugural report is an exploration of the remarkable advancements in screening and the field of drug discovery.
Our inaugural report is an exploration of the remarkable advancements in cancer research and the field of drug discovery.
A new approach called reverse metabolomics has discovered molecules that may serve as a biomarker or a therapeutic target for IBD.
By mapping the genome, scientists have discovered how IKAROS enables differentiation of hematopoietic stem cells into B cells.
Carboxylic nanodiamonds could be a therapeutic agent for cancer, as melanoma cells treated with them showed little to no metastasis.
Researchers, using high-resolution mapping and mathematical modelling, have found mechanisms controlling mutation-driven diseases.
Findings about how erythrocytes interact with brain capillaries offers new potential treatments for brain microhaemorrhages.
An advanced computational model enables scientists to study how cancer cells navigate through blood vessels.
New findings about how RBM10 inhibits lung cancer growth offers potential for an anti-cancer drug and more personalised treatment.